Although it exhibits a high degree of tumour-specific expression [3,5], and is one of the 16 cancer-related genes represented in the Oncotype DX assay [6], the role of survivin as a breast cancer biomarker has remained the subject of much debate (1). This evidence concerns the gene BIRC5 and breast carcinoma.